Who is Anthony Bosch?

40 Comments

In the wake of ESPN’s Tuesday night report about Major League Baseball’s investigation and potential suspension of as many as two dozen players linked to the Biogenesis clinic in Miami, the spotlight has shone on one man more than any other: Anthony Bosch, the owner of the Biogenesis of America clinic and now the man who is reportedly prepared to turn over everything he knows about his famous clients to Major League Baseball.

But who is Anthony Bosch? What do we know about him?

Not much. We know he was born in Miami and grew up in comfortable circumstances. His father, Pedro Bosch, has been a successful physician for nearly 40 years. He has had multiple marriages and multiple failed businesses, with Biogenesis being the last.

Biogenesis was an “anti-aging” clinic that, superficially anyway, was like many in Florida. It was just across U.S. 1 from the University of Miami, housed in what was once a motel. Like other anti-aging clinics, it was a quasi-medical establishment which offered its mostly wealthy clients assistance in weight loss, physical fitness, and in some cases psychological services. Better living through therapy and chemistry. Such clinics are not licensed or regulated by the State of Florida.

The “quasi” part of that comes from the fact that Bosch is not a physician. His only known degree was obtained in 2009 from the Central America Health Sciences University in Belize, which he claimed to be a medical degree and displayed it on his office wall. According to the Miami New Times he wore a lab coat with “Dr. Tony Bosch” on it and gave the impression to many that he was, in fact, a doctor.

He did something else only doctors are allowed to do: as the New York Times reported in February, Bosch would obtain prescription drugs for his patients, including human growth hormone. His methods of doing so is unknown and are subject to an investigation by the Florida Department of Health and referrals to the Miami State Attorney’s office and the Florida Attorney General’s office. The New York Times report on Biogenesis in February described Bosch’s clinic as disheveled and disorganized. A former business partner of Bosch’s was surprised that Bosch was alleged to have worked with high-profile athletes, saying “I don’t know how the guy can tie his shoes, let alone have A-Rod as a client.”

But his business records, obtained by the Miami New Times suggest that he did indeed supply performance enhancing drugs to many ballplayers, A-Rod included. Most of the drug distributions were reported to have been made through intermediaries rather than to the ballplayers themselves. One of the alleged intermediaries was an employee of player agents the Levinson brothers. In the case of Alex Rodriguez, however, Bosch is alleged to have actually injected the player personally, doing so at Rodriguez’s home. All involved have denied the allegations.

Bosch himself denied any allegation that he supplied performance enhancing drugs to players, telling ESPN in April that such allegations are lies:

“I have been accused, tried and convicted in the media. And so I think have been falsely accused throughout the media … I am a nutritionist. I don’t know anything about performance-enhancing drugs.”

But that has all changed now. Major League Baseball sued Bosch in March, alleging that he tortiously interfered with baseball’s Joint Drug Agreement, damaging the game. On Thursday morning it was reported that, some time after that suit was filed, Bosch approached Alex Rodriguez in an effort to obtain his financial assistance in the face of the lawsuit and other investigations into his activities. Rodriguez is reported to have denied any assistance to Bosch.

Now, Bosch and Major League Baseball are reported to have come to an agreement in which the lawsuit will be dismissed against him, he will provide testimony and documents to Major League Baseball in furtherance of its investigation into Biogenesis-connected ballplayers and will indemnify him for any legal repercussions occasioned by his cooperation. While the baseball officials have not yet spoken to Bosch, it is reasonable to assume that the league’s cooperation with Bosch is based on him providing information which would implicate ballplayers in the use of performance enhancing drugs.

Mets trade Curtis Granderson to the Dodgers

Getty Images
1 Comment

The Mets traded centerfielder Curtis Granderson to the Dodgers for cash considerations or a player to be named later, the teams announced late Friday night. Granderson was rumored to be drawing interest from teams earlier in the week, and found a landing place after slashing .256/.360/.721 since the start of the month. In a corresponding move, the Dodgers designated right-hander Dylan Floro for assignment to clear roster space for the outfielder.

As a whole, the 36-year-old’s 2017 campaign has been a tad underwhelming. Granderson entered Saturday batting .228/.334/.481 with 19 home runs and an .815 OPS through 395 PA, and accrued 1.7 fWAR to the 5.1 fWAR he produced during his pennant-winning, MVP-contending season in 2015. Still, with under $4 million remaining on his contract, another 20+ homer season around the corner and the defensive chops to man center field, it looks like a prudent deal for the Dodgers as they continue to bulldoze their way to the playoffs this fall.

The club has yet to outline their plans for Granderson, but his addition to a crowded outfield could displace centerfielder Joc Pederson, who turned in a meager .214/.329/.415 batting line through 292 PA in 2017. It could also have ramifications for fellow veteran Andre Ethier, assuming he’s healthy enough to compete for a starting role when he comes off the 60-day disabled list in September. The Mets, meanwhile, are expected to lean more heavily on rookie outfielder Brandon Nimmo, who’s made just five starts this season after struggling to get consistent playing time on the field.

Corey Kluber exits game with right ankle sprain

Getty Images
Leave a comment

Indians’ right-hander Corey Kluber was removed from the sixth inning of his start on Friday night, bringing a streak of 14 starts with 8+ strikeouts to an unfortunate end after he sprained his right ankle. Kluber stumbled off the mound while trying to field a base hit from Eric Hosmer and was seen visibly limping as he moved to cover first base. He was allowed to stay in the game for one more batter, but quickly yielded a three-pitch single to Melky Cabrera and left the mound with head athletic trainer James Quinlan.

It was a poor ending to another strong outing by the right-hander, who delivered 5 1/3 innings of one-run, four-strikeout ball and took his 12th win of the season after the Indians amassed a nine-run lead. Postgame comments by Cleveland skipper Terry Francona suggest that Kluber isn’t facing a serious setback after sustaining the sprain, however, and might even be good to go by the time his next start comes around on Wednesday.

While the Royals escaped Friday’s loss without injury, the 10-1 drubbing pushed them 6.5 games back of the division lead and half a game behind the Twins and Angels for the second AL wild card berth. They’ll host a rematch on Saturday at 7:15 ET, with left-hander Jason Vargas set to face off against Indians’ righty Trevor Bauer.